Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Predictors of Religious Orientation Attitudes in Menopausal Women (MENO-RO)

26 augustus 2026 bijgewerkt door: Aslıhan Turan, KTO Karatay University

Predictors of Attitudes Toward Religious Orientation in Menopausal Women: A Cross-Sectional Study

This descriptive, cross-sectional study examines whether the severity of menopausal symptoms and attitudes toward sexual myths predict intrinsic religious orientation in menopausal women. Menopause is a multidimensional transition with biological, psychological, social and spiritual aspects, and in societies with a strong cultural and religious fabric women may draw on religious orientation as a coping and meaning-making resource. Participants are healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease, recruited in Konya, Turkey. Data are collected face to face using a personal information form, the Menopause Rating Scale, the Intrinsic Religious Orientation Scale and the Sexual Myths Scale, and analysed with multiple regression.

Studie Overzicht

Gedetailleerde beschrijving

Background:

Menopause is a multidimensional transition in a woman's life with biological, psychological, social and spiritual dimensions. With increasing life expectancy, women spend roughly a third of their lives in the menopausal period. The decline in oestrogen is associated with hot flushes, sleep disturbance, mood fluctuations and sexual dysfunction, which can adversely affect quality of life. The literature emphasises that the menopause experience is shaped not only biologically but also by sociocultural factors and religious beliefs, and that religious and spiritual orientation can increase psychological resilience and reduce anxiety and stress. Sexual dysfunction is highly prevalent in this period, and sexuality is closely linked to lifestyle, cultural roles, religious beliefs and societal myths; low sexual awareness and adoption of sexual myths may intensify the perceived severity of menopausal symptoms.

Aim:

To determine the predictive effect of the physical and psychological symptoms of menopause and of attitudes toward sexual myths on the intrinsic religious orientation of menopausal women.

Design and setting:

Descriptive, cross-sectional design. The study population comprises healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey. The sample consists of women who meet the inclusion criteria and volunteer to participate.

Sample size:

Calculated with G*Power 3. For a linear multiple regression model with a medium effect size of 0.15, power of 0.95 and a Type I error of 0.05, a minimum of 89 participants is required. Allowing for a possible 10 percent data loss, 97 participants are planned.

Measures:

A personal information form (15 items covering sociodemographic and obstetric characteristics), the Menopause Rating Scale (MRS), the Intrinsic Religious Orientation Scale and the Sexual Myths Scale. Written informed consent is obtained; author permissions for the scales are obtained by email. Data are collected face to face.

Statistical analysis:

Analyses are performed with IBM SPSS Statistics v29.0. Normality is assessed with visual and analytical methods (Kolmogorov-Smirnov test). Descriptive statistics are reported as mean and standard deviation or median (minimum to maximum) as appropriate. Multiple regression models are built to estimate regression coefficients and 95 percent confidence intervals for the relationships between religious orientation and age, number of pregnancies, menopause duration, menopause symptom severity and sexual myths. Group comparisons use the Mann-Whitney U and Kruskal-Wallis tests where appropriate. Significance is set at p less than 0.05.

Ethics:

Institutional permission and ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University before the study begins. Written informed consent is obtained from all participants.

Studietype

Observationeel

Inschrijving (Geschat)

97

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

      • Konya, Turkije (Türkiye)
        • Werving
        • Recruitment site (to be specified), Konya
        • Contact:
          • Aslihan Turan
        • Hoofdonderzoeker:
          • Aslihan Turan

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Ja

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey, who volunteer and provide written informed consent.

Beschrijving

Inclusion Criteria:

  • Woman aged 49 to 59 years
  • Diagnosis of menopause
  • No chronic health problem
  • Volunteers to participate and provides written informed consent

Exclusion Criteria:

* Presence of a chronic disease (e.g. cardiac disease, diabetes, hypertension)

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Menopausal women aged 49 to 59
Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease (such as cardiac disease, diabetes or hypertension), recruited in Konya, Turkey, who volunteer to participate. Participants complete a single battery of self-report scales collected face to face; no intervention is applied.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Intrinsic religious orientation (Intrinsic Religious Orientation Scale)
Tijdsspanne: Single assessment at enrollment (Day 1)
The Intrinsic Religious Orientation Scale (Hoge, 1972; Turkish standardisation by Karaca, 2001) contains 10 items measuring intrinsic religious motivation. Seven items are positively worded and three are negatively worded and reverse coded. Items are rated on a 5-point Likert format scored from 0 (weakest) to 4 (strongest), giving a total score of 0 to 40, with higher scores indicating stronger intrinsic religious orientation.
Single assessment at enrollment (Day 1)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Menopausal symptom severity (Menopause Rating Scale, MRS)
Tijdsspanne: Single assessment at enrollment (Day 1)
The Menopause Rating Scale (Schneider et al., 2000; Turkish adaptation by Can Gurkan, 2005) is an 11-item scale with three subscales: somatic complaints, psychological complaints and urogenital complaints. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe), giving a total score of 0 to 44, with higher scores indicating greater symptom severity.
Single assessment at enrollment (Day 1)
Sexual myths (Sexual Myths Scale, SMS)
Tijdsspanne: Single assessment at enrollment (Day 1)
The Sexual Myths Scale (Golbasi et al., 2016) is a 28-item, 5-point Likert scale with eight subscales (sexual orientation, gender, age and sexuality, sexual behaviour, masturbation, sexual violence, sexual intercourse and sexual satisfaction). The total score ranges from 28 to 140, with higher scores indicating a greater likelihood of holding sexual myths.
Single assessment at enrollment (Day 1)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Aslihan Turan, KTO Karatay University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

26 augustus 2026

Primaire voltooiing (Geschat)

1 februari 2027

Studie voltooiing (Geschat)

2 februari 2027

Studieregistratiedata

Eerst ingediend

26 augustus 2026

Eerst ingediend dat voldeed aan de QC-criteria

26 augustus 2026

Eerst geplaatst (Werkelijk)

1 september 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

1 september 2026

Laatste update ingediend die voldeed aan QC-criteria

26 augustus 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren